Nephrotic vs. Nephritic Syndrome: Comparison and Differentiation

Core Idea

Nephrotic syndrome features severe proteinuria (>3.5 g/day), hypoalbuminemia, edema, and hyperlipidemia from podocyte disease (minimal change, FSGS, membranous GN) causing selective proteinuria with intact RBC filtration. Nephritic syndrome features hematuria, dysmorphic RBCs, RBC casts, and hypertension from proliferative inflammation (post-infectious, IgA, lupus GN) causing non-selective proteinuria and glomerular bleeding. Some diseases (IgA nephropathy, lupus GN) present with nephritic features but can evolve to nephrotic features as proteinuria increases.

How It's Best Learned

Create a comparison table of clinical and laboratory features. Study representative diseases in each category. Understand why edema is different in nephrotic syndrome (from hypoalbuminemia reducing oncotic pressure) versus nephritic syndrome (from salt retention and hypertension).

Common Misconceptions

Proteinuria alone does not define nephrotic versus nephritic; the proteinuria must be >3.5 g/day for nephrotic syndrome. Hematuria is not specific to nephritic GN; it indicates any glomerular bleeding including in nephrotic syndrome from certain diseases. Some patients have features of both ('nephrotic-nephritic') complicating classification.

Explainer

You have already studied the glomerular filtration barrier and understand that it normally retains plasma proteins, particularly albumin, through a combination of size and charge selectivity. You have also encountered the major types of glomerulonephritis and understand that different immune mechanisms can injure different parts of this barrier. Nephrotic and nephritic syndromes are the two fundamental clinical presentations of glomerular disease — and while they are often taught as opposites, they reflect a spectrum of pathological mechanisms that sometimes overlap.

Nephrotic syndrome arises when the glomerular barrier loses its selectivity for protein while largely preserving blood cell retention. The fundamental lesion is podocyte injury — foot process effacement disrupts the charge barrier and allows large amounts of albumin and other proteins to filter through. The result is massive proteinuria (>3.5 g/day in adults, the diagnostic threshold), the sine qua non of the syndrome. Everything else in nephrotic syndrome follows from protein loss: hypoalbuminemia develops as albumin spills into the urine faster than the liver can synthesize it; the resulting fall in plasma oncotic pressure shifts Starling forces toward interstitial fluid accumulation, producing the soft, pitting edema characteristic of nephrotic syndrome (periorbital in children who lie flat, ankle and pedal in ambulatory adults). The liver compensates for low oncotic pressure by upregulating lipoprotein synthesis, causing hyperlipidemia and lipiduria (lipid-laden granular casts in urine). The primary diseases — minimal change disease, focal segmental glomerulosclerosis (FSGS), membranous nephropathy — all produce podocyte injury without significant glomerular inflammation.

Nephritic syndrome involves inflammatory injury to the glomerular capillary wall: infiltrating immune cells, proliferation of resident endothelial and mesangial cells, and disruption of the capillary wall that allows red blood cells to leak through. The diagnostic signature is hematuria with dysmorphic RBCs (particularly acanthocytes, whose spiky irregular shape is produced by RBCs squeezing through the disrupted GBM) and RBC casts (red cells embedded in Tamm-Horsfall protein matrix, indicating that bleeding originated in the nephron). Inflammatory mediators cause sodium and water retention that raises blood pressure, producing hypertension and moderate edema — a different mechanism than the oncotic-pressure-driven edema of nephrotic syndrome. Proteinuria is present but typically milder, because the primary problem is inflammation rather than selective protein leakage. Post-infectious GN, IgA nephropathy, and lupus nephritis are the characteristic causes.

The key to differentiating the syndromes in practice is integrating urine sediment findings with the degree of proteinuria. RBC casts and dysmorphic red cells on urine microscopy point immediately to nephritic disease, regardless of protein level. Heavy proteinuria >3.5 g/day without hematuria points to nephrotic disease. The diagnostically challenging patients are those with overlap features — IgA nephropathy (typically nephritic) can develop nephrotic-range proteinuria as disease progresses; membranoproliferative GN can present with both heavy proteinuria and RBC casts. For these patients, renal biopsy provides the definitive classification by identifying the morphological pattern (mesangial proliferation, membranous thickening, focal sclerosis) and immune deposit type (IgA, IgG, complement). This histological diagnosis determines treatment — the clinical syndrome classification is the starting point, but the biopsy result is the guide for specific immunosuppressive therapy.